DIRS.INFO The most relevant business & tech news

Aug 21 (Reuters) - Indivior (INDV.L) has agreed to pay $30 million to settle a class action lawsuit filed in a U.S. court by health plans accusing the drugmaker of illegally suppressing generic competition for its opioid addiction treatment Suboxone. The settlement, disclosed on Saturday in a filing by lawyers for the health plans in federal court in Philadelphia, must still be approved by a judge. Indivior is still facing claims by drug wholesalers that bought Suboxone from the Virginia-based company directly, with a trial scheduled in October. Lawyers for the health plans did not immediately respond to requests for comment. Indivior agreed in June to pay $102.5 million to settle related claims by 41 U.S. states and Washington, D.C.

Persons: Indivior, Mark Crossley, Suboxone, Brendan Pierson, Will Dunham, Alexia Garamfalvi Organizations: U.S, D.C, U.S . Centers for Disease Control, Thomson Locations: U.S, Philadelphia, Virginia, Washington, United States, New York

☆ The telehealth services we all relied on during COVID are fading away — but telemedicine may be entering a new era as providers look to bring the clinic home
▼ + stars: | 2023-06-28 | by ( Natalie Rahhal | ) www.businessinsider.com time to read: +7 min

But it's exhausted the capabilities of asynchronous care, one healthcare expert told Insider. The answer may lie in in-home monitoring technology, healthcare experts told Insider, which could be the next phase of telemedicine. Another example of a telemedicine model that uses in-home monitoring to expand access to care is the startup Bicycle Health. But there are obstacles to getting this kind of care to patients, including doctors' resistance to telemedicine and federal and state regulation. "For one-quarter century, this has been the domain of states," Kyle Zebley, senior vice president of public policy at the American Telemedicine Association, told Insider.

Persons: it's, Alana Saltz, Saltz, Ateev, Mehrotra, Danny Nieves, Kim, Nieves, telehealth, —, Kyle Zebley, Zebley, that's Organizations: Healthcare, Morning, Harvard University, Technology, Health, Bicycle Health, American Telemedicine Association, McKinsey Locations: COVID, —

The pan-European STOXX 600 index (.STOXX) ended 0.4% lower after a survey showed the U.S. services sector barely grew in May, while factory orders rose less than expected. "There's a bit of profit taking after some of the moves we've had recently," said Steve Sosnick, chief strategist at Interactive Brokers. "The economic reports that we've gotten around the world (signal) a somewhat slowing economy." Shares of Indivior Plc (INDV.L) jumped 7.8% to top the STOXX 600 index after the drugmaker agreed to pay $102.5 million to settle a lawsuit for its opioid addiction treatment Suboxone. Reporting by Shreyashi Sanyal in Bengaluru; Editing by Sherry Jacob-Phillips, Dhanya Ann Thoppil and Richard ChangOur Standards: The Thomson Reuters Trust Principles.

Persons: we've, Steve Sosnick, Christine Lagarde, Joachim Nagel, Shreyashi Sanyal, Sherry Jacob, Phillips, Dhanya Ann Thoppil, Richard Chang Organizations: PMI, Interactive, U.S . Federal, European Central Bank, Amazon.com Inc, Indivior Plc, Trendyol, Viaplay, Volvo, Copenhagen Stock Exchange, Thomson Locations: U.S, Alibaba, Swedish, Sweden, Bengaluru

☆ European shares open flat; London leads on oil boost
▼ + stars: | 2023-06-05 | by ( ) www.reuters.com time to read: +1 min

June 5 (Reuters) - European shares opened flat on Monday as markets failed to catch the tailwind from a bounce seen last week, while London stocks led regional gains following upbeat performances by energy firms on the back of higher oil prices. The pan-European STOXX 600 index (.STOXX) held its ground at 462.46 points, while London's FTSE 100 (.FTSE) index led gains with a 0.5% climb. The European oil & gas sector index (.SXEP) rose 1%, buttressed by stronger oil prices after top global exporter Saudi Arabia pledged to cut production by another 1 million barrels per day from July. Shares of Indivior Plc (INDV.L) surged 11% to top the STOXX 600 Index after the drugmaker agreed to pay $102.5 million to settle a lawsuit for its opioid addiction treatment Suboxone. Reporting by Shreyashi Sanyal in Bengaluru; Editing by Sherry Jacob-PhillipsOur Standards: The Thomson Reuters Trust Principles.

Persons: Shreyashi Sanyal, Sherry Jacob, Phillips Organizations: FTSE, Saudi, Markets, U.S . Federal, Indivior Plc, Thomson Locations: London, Saudi Arabia, U.S, Bengaluru

☆ Indivior opioid settlement makes purer M&A case
▼ + stars: | 2023-06-05 | by ( ) www.reuters.com time to read: +2 min

LONDON, June 5 (Reuters Breakingviews) - Indivior (INDV.L) is one step closer to becoming a takeover target. Litigation risks have weighed down Indivior in the years following the company’s spinoff from Reckitt Benckiser (RKT.L) in 2014. The group still has lawsuits to settle over the same charges with insurers and patients. With its litigation risks easing, Indivior could soon lure larger cash rich pharmaceutical companies keen to access a market that is sadly showing no signs of decline. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.

Persons: Reckitt, Roche, Indivior, Aimee Donnellan, Neil Unmack, Streisand Neto Organizations: Reuters, Suboxone, AstraZeneca, U.S . Centers for Disease Control, Twitter, Toyota, Thomson Locations: U.S

Companies Indivior PLC FollowJune 2 (Reuters) - Indivior Plc (INDV.L) said on Friday it agreed to pay $102.5 million to settle a lawsuit by dozens of U.S. states accusing it of illegally suppressing generic competition for its opioid addiction treatment Suboxone. Suboxone was approved for U.S. sale in 2002, and Indivior had the exclusive right to sell the treatment in tablet form until 2009. States said Indivior switched to an oral film version of Suboxone from a tablet version to extend its monopoly, just as generic manufacturers were poised to sell their own lower-cost tablets. Generic tablets obtained federal approval in 2013. Indivior expects to pay the $102.5 million in cash this month.

Persons: drugmaker, Indivior, Suboxone, Josh Kaul, Mariam Sunny, Jonathan Stempel, Maju Samuel, Matthew Lewis Organizations: Indivior, D.C, U.S, U.S . Centers for Disease Control, Thomson Locations: Chesterfield , Virginia, U.S, Washington, Indivior's, Philadelphia, Suboxone, Wisconsin, United States, Bengaluru, New York

☆ Warren tells FTC she is "particularly concerned" about Amgen and Indivior deals
▼ + stars: | 2023-01-26 | by ( ) www.reuters.com time to read: +2 min

Warren said that both Amgen and Horizon Therapeutics "have engaged in brazen price increases," including on Amgen's Enbrel for arthritis and Horizon’s Krystexxa, a gout medication. She noted that the FTC had settled with Indivior and its former parent over its attempt to protect its monopoly of the opioid addiction treatment Suboxone. Indivior makes Sublocade -- a slow-release treatment for opioid addiction that is administered monthly. "The FTC should strongly consider Indivior's history of anti-competitive and deceptive practices when evaluating howIndivior might behave after this potential transaction is completed," wrote Warren. Warren noted that the FTC, which has long focused on healthcare mergers, said in 2021 that it would prioritize pharmaceutical acquisitions.

Timothy York knows what works to treat his decadeslong opioid addiction: Suboxone, a medication that effectively quiets cravings. Since York arrived in federal prison in 2008, he has been held in a series of facilities awash with contraband drugs and violence. Yet the federal prisons are treating only a fraction — less than 10% — of the roughly 15,000 prisoners who need it, according to the bureau’s estimates. Some say the issues stem from a culture at the bureau that is skeptical of addiction medication and pits staff against prisoners. He was using an underground supply of Suboxone at USP-Coleman, the federal prison in Florida where he was incarcerated, but it was erratic.

☆ As overdoses soar in rural America, more clinicians are prescribing addiction medications
▼ + stars: | 2022-11-30 | by ( Tony Leys | Kaiser Health News | ) www.nbcnews.com time to read: +12 min

The Health Resources and Services Administration, which aims to improve health care for underserved people, offers many of these grants. But the use of methadone for addiction treatment is tightly regulated, due to concerns that it can be abused. Federal regulators approved Suboxone in 2002, opening an avenue for addiction treatment in towns without methadone clinics. Or a patient’s primary doctor could take over the buprenorphine treatment after an addiction treatment specialist stabilizes a patient. Storjohann said some health care professionals believe addiction treatment would lead to frustration, because patients can repeatedly relapse.

Search resuls for: "Suboxone"

9 mentions found